Abstract
Thygeson's superficial punctate keratitis (Thygeson's SPK) is a distinct clinical entity, characterized by round conglomerates of discrete, granular, white-gray, fine intraepithelial dots without conjuctival involvement. The only effective treatment with regard to relieving symptoms and diminishing lesions has been topical corticosteroids, but their prolonged use can be associated with severe side-effects. The purpose of this study is to present the long-term results of the use of 2% topical cyclosporin A in olive oil in Thygeson's SPK. Eight patients diagnosed as having Thygeson's SPK were included. All the patients were treated with 2% cyclosporin dissolved in olive oil four times a day for three months, and two times a day for one month before withdrawing therapy. The follow-up period ranged from twelve to twenty-five months. The number of corneal lesions varied between 5 and 15 before treatment. After cyclosporin treatment, no corneal lesion was observed and the cornea remained clear after the follow-up period. In conclusion, 2% cyclosporin in olive oil is a safe alternative to corticosteroids in the treatment of Thygeson's SPK, and resulted in satisfactory control of the condition.
Similar content being viewed by others
References
Thygeson P. Superficial punctate keratitis (SPK). JAMA 1950; 144: 1544–1549.
Braley AB, Alexander RC. Superficial punctate keratitis: isolation of a virus. Arch Ophthalmol 1953; 50: 147–254.
Lemp MA, Chambera RW Jr, Lundy J. Virus isolate in superficial punctate keratitis. Arch Ophthalmol 1974; 91: 8–10.
Forstot SL, Binder PS. treatment of Thygesonss superficial punctate keratopathy with soft contact lenses. Am J Ophthalmol 1979; 88: 186–189.
Schwab IR, Thygeson P. Thygeson superficial punctate keratopathy. In Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection and immunity. St Louis: Mosby, 1996: 403–407.
Darrell RW. Thygeson's superficial punctate keratitis: natural history and association with HLA DR3. Trans Am Ophthalmol Soc 1982; 79: 486–516.
Tabbara KF, Ostler HB, Dawson C, Oh J. Thygeson's superficial punctate keratitis. Ophthalmology 1981; 88: 75–77.
Nesburn AB, Lowe III GH, Lepoff NJ, Maguen H. Effect of topical trifluridine on Thygeson's superficial punctate keratitis. Ophthalmology 1984; 91: 1188–1192.
Holsclaw DS, Wong IG, Sherman M. Masked trial of topical cyclosporine A in the treatment of refractory Thygeson's superficial punctate keratitis. Invest Ophthalmol Vis Sci 1994; 35 (ARVO abstract): 1302.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Del Castillo, J.M.B., Del Castillo, J.B. & Garcia-Sanchez, J. Effect of topical cyclosporin A on Thygeson's superficial punctate keratitis. Doc Ophthalmol 93, 193–198 (1997). https://doi.org/10.1007/BF02569059
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02569059